BG108531A - Нови х...'...роарилни производни, 'яхно'о пол"-аван... и използван... - Google Patents

Нови х...'...роарилни производни, 'яхно'о пол"-аван... и използван... Download PDF

Info

Publication number
BG108531A
BG108531A BG108531A BG10853104A BG108531A BG 108531 A BG108531 A BG 108531A BG 108531 A BG108531 A BG 108531A BG 10853104 A BG10853104 A BG 10853104A BG 108531 A BG108531 A BG 108531A
Authority
BG
Bulgaria
Prior art keywords
piperazin
dioxin
dihydrobenzo
ethylsulfanyl
chloro
Prior art date
Application number
BG108531A
Other languages
Bulgarian (bg)
English (en)
Inventor
Mario Rottlaender
Ejner K. Moltzen
Ivan Mikkelsen
Thomas Ruhland
Kim Andersen
Christian Krog-Jensen
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of BG108531A publication Critical patent/BG108531A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG108531A 2001-06-29 2004-01-14 Нови х...'...роарилни производни, 'яхно'о пол"-аван... и използван... BG108531A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101036 2001-06-29
PCT/DK2002/000435 WO2003002556A1 (en) 2001-06-29 2002-06-27 Novel heteroaryl derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
BG108531A true BG108531A (bg) 2004-08-31

Family

ID=8160598

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108531A BG108531A (bg) 2001-06-29 2004-01-14 Нови х...'...роарилни производни, 'яхно'о пол"-аван... и използван...

Country Status (27)

Country Link
US (2) US20040248883A1 (ru)
EP (1) EP1399438B1 (ru)
JP (1) JP2004535449A (ru)
KR (1) KR20040019026A (ru)
CN (1) CN1310909C (ru)
AT (1) ATE312094T1 (ru)
AU (1) AU2002344949B2 (ru)
BG (1) BG108531A (ru)
BR (1) BR0210401A (ru)
CA (1) CA2451228A1 (ru)
CZ (1) CZ2004156A3 (ru)
DE (1) DE60207857T2 (ru)
DK (1) DK1399438T3 (ru)
EA (1) EA006203B1 (ru)
ES (1) ES2252471T3 (ru)
HK (1) HK1068622A1 (ru)
HU (1) HUP0400344A2 (ru)
IL (1) IL158828A0 (ru)
IS (1) IS2425B (ru)
MX (1) MXPA03011769A (ru)
NO (1) NO326514B1 (ru)
NZ (1) NZ529460A (ru)
PL (1) PL365249A1 (ru)
SI (1) SI1399438T1 (ru)
SK (1) SK652004A3 (ru)
UA (1) UA75407C2 (ru)
WO (1) WO2003002556A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ529461A (en) * 2001-06-29 2005-09-30 H Novel indole derivatives
DE60231507D1 (de) 2001-07-20 2010-07-01 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
JP4741487B2 (ja) * 2003-07-02 2011-08-03 コーラス ファーマ,インコーポレイティド アズトレオナムl−リジン及びそれを調製するための方法
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
JP2008521771A (ja) 2004-11-26 2008-06-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 改良された抗精神病活性および抗不安症活性を有するイソキサゾリン−インドール誘導体
CN102822167A (zh) 2010-01-04 2012-12-12 埃南蒂亚有限公司 用于制备利伐沙班的方法及其中间体
CN104672364A (zh) 2010-04-12 2015-06-03 湖南石油化学株式会社 使用包含噻吩稠合的环戊二烯基配体的过渡金属化合物制备烯烃-二烯共聚物的方法
KR101384412B1 (ko) 2010-04-12 2014-04-25 롯데케미칼 주식회사 티오펜-축합고리 사이클로펜타디에닐 리간드를 포함하는 전이금속 화합물을 사용한 폴리프로필렌의 제조방법
KR100986301B1 (ko) 2010-04-12 2010-10-07 아주대학교산학협력단 테트라하이드로퀴놀린 유도체로부터 유래한 티오펜-축합고리 싸이클로펜타디에닐 4족 금속 화합물 및 이를 이용한 올레핀 중합
ES2596717T3 (es) 2010-04-12 2017-01-11 Lotte Chemical Corporation Composición de catalizador para la polimerización de olefina y procedimiento de preparación de poliolefina usando la misma
JP5567209B2 (ja) 2010-04-12 2014-08-06 ロッテ ケミカル コーポレーション オレフィン重合用担持触媒およびこれを用いたポリオレフィンの製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2667068B1 (fr) * 1990-09-26 1994-09-09 Adir Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
NZ529461A (en) 2001-06-29 2005-09-30 H Novel indole derivatives

Also Published As

Publication number Publication date
ATE312094T1 (de) 2005-12-15
PL365249A1 (en) 2004-12-27
US20080027071A1 (en) 2008-01-31
UA75407C2 (en) 2006-04-17
EA200400102A1 (ru) 2004-04-29
HK1068622A1 (en) 2005-04-29
DK1399438T3 (da) 2006-04-18
CA2451228A1 (en) 2003-01-09
IS2425B (is) 2008-10-15
WO2003002556A1 (en) 2003-01-09
DE60207857D1 (de) 2006-01-12
US20040248883A1 (en) 2004-12-09
SK652004A3 (en) 2004-09-08
NZ529460A (en) 2005-09-30
AU2002344949B2 (en) 2007-05-24
NO326514B1 (no) 2008-12-22
EP1399438A1 (en) 2004-03-24
CN1310909C (zh) 2007-04-18
HUP0400344A2 (hu) 2004-09-28
DE60207857T2 (de) 2006-07-20
SI1399438T1 (sl) 2006-04-30
BR0210401A (pt) 2004-08-17
NO20035673L (no) 2003-12-18
EP1399438B1 (en) 2005-12-07
US7393845B2 (en) 2008-07-01
NO20035673D0 (no) 2003-12-18
JP2004535449A (ja) 2004-11-25
KR20040019026A (ko) 2004-03-04
EA006203B1 (ru) 2005-10-27
IL158828A0 (en) 2004-05-12
IS7021A (is) 2003-11-10
MXPA03011769A (es) 2004-04-02
CZ2004156A3 (cs) 2004-05-12
CN1520410A (zh) 2004-08-11
ES2252471T3 (es) 2006-05-16

Similar Documents

Publication Publication Date Title
US7393845B2 (en) Heteroaryl derivates, their preparation and use
DK2937341T3 (en) 4- (BENZYL) -PIPERAZINE-1-CARBOXYLIC ACID PHENYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF FATTY ACID HYDROLASE (FAAH) FOR TREATING ANALYSIS, PAIN AND OTHER CONDITIONS
US20160060231A1 (en) Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
KR20000005505A (ko) 피페리딘 및 피롤리딘
TW200526630A (en) Novel pyridine derivatives
AU2002344949A1 (en) Novel heteroaryl derivatives, their preparation and use
JP2001520224A (ja) 2−置換1,2−ベンジイソチアゾール誘導体およびそのセロトニン拮抗薬(5−ht1a、5−ht1b、5−ht1d)としての使用
EP1399434B1 (en) Novel indole derivatives
AU2002344950A1 (en) Novel indole derivatives
KR100470691B1 (ko) 시클로부타인돌카르복사미드 화합물, 이의 제조 방법 및이를 함유하는 약제 조성물
AU2007200149A1 (en) Vanilloid receptor ligands and their use in treatments